Skip to main content
Log in

Barriers and countermeasures in developing traditional Chinese medicine in Europe

  • Commentary
  • Published:
Frontiers of Medicine Aims and scope Submit manuscript

Abstract

Traditional Chinese medicine (TCM) is one of the unique cultural treasures of Chinese; it represents a significant feature and prominent advantage of the healthcare cause in China. Data in this paper were fromWorld Health Organization, Chinese Bureau of Statistics, China National Knowledge Infrastructure, and PubMed. In recent years, TCM has established a solid foundation in Europe, which made great strides in legislation, education, research, and international exchange, and has enjoyed a vast development space in the continent. Now, TCM is embracing unprecedented development opportunities in Europe. At the same time, the stiff international competition poses a grave threat to China’s TCM industry. With multiple cultural, legal, and institutional challenges, as well as talent shortages in the way, TCM is now facing many difficulties in Europe. To fully prepare and enact active and vigorous steps to seize opportunities, we should have a clear picture about the serious challenges hampering TCM development in Europe. The TCM development at overseas markets has shifted from a spontaneous trade activity into a national strategy spearheaded by the government and participated in by multiple stakeholders. We should make a systematic, comprehensive, and sustainable push in fields such as TCM therapy, healthcare, education, research, culture, and industry development. The ultimate goal is to bring TCMs to the global market and allow them to play a role in safeguarding public health along with modern medicines.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fan DM. The Year in Chinese Academy of Engineering (5). Xi’an: The Fourth Military Medical University press, 2014 (in Chinese)

    Google Scholar 

  2. World Health Organization. WHO Traditional Medicine Strategy 2014–2023. Geneva, 2013

  3. World Health Organization. WHO traditional medicine strategy 2002–2005. Geneva, 2002 (WHO/EDM/TRM/2002.1)

  4. World Health Organization. WHO medicines strategy 2004–2007. Geneva, 2004 (WHO/EDM/2004.5)

  5. World Health Organization. Continuity and change-implementing the third WHO medicines strategy: 2008–2013. Geneva, 2009 (WHO/EMP/2009.1)

  6. World Health Organization. National policy on traditional medicine and regulation of herbal medicines: report of a WHO global survey. Geneva, 2005

  7. World Health Organization. C. Traditional medicine. In: Implementation of resolutions (progress reports). Report by the Secretariat. Geneva, 2005

  8. Wang M, Franz G. The role of the European Pharmacopoeia (Ph Eur) in quality control of traditional Chinese herbal medicine in European Member States. World J Tradit Chin Med 2015; 1(1): 5–15

    Article  Google Scholar 

  9. Yu WD, Guan T. Economic effect analysis and countermeasure research of Chinese medicine in China’s free trade zone arrangements with Switzerland. Economist (Jing Ji Shi) 2014; 9: 100–102 (in Chinese)

    Google Scholar 

  10. Xiao ZZ, Xing R, Guo XG. The current state of Chinese medicine in the Europe and thoughts on its development. J Hunan Univ Tradit Chin Med (Hunan Zhong Yi Yao Da Xue Xue Bao) 2012; 32(5): 75–78 (in Chinese)

    Google Scholar 

  11. Yao ZJ, Wang ZQ, Yu JB, Zheng XF. View at the development of acupuncture from the success of application for world immaterial heritages with acupuncture. J Hubei Univ Tradit Chin Med (Hubei Zhong Yi Yao Da Xue Xue Bao) 2011; 13(4): 42–44 (in Chinese)

    Google Scholar 

  12. Wang CY, Bai XY, Wang CH. Traditional Chinese medicine: a treasured natural resource of anticancer drug research and development. Am J Chin Med 2014; 42(3): 543–559

    Article  CAS  PubMed  Google Scholar 

  13. Jiang YG. Several problems of international development of Chinese medicine-medical knowledge and analysis in Swiss. J Tradit Chin Med (Zhong Yi Za Zhi) 2012; 53(9): 799–801 (in Chinese)

    Google Scholar 

  14. Weng XY. A brief analysis of 2004/24/EC-EU traditional herbal medicine law. Foreign Med Sci 2004; 26(5): 259–261

    Google Scholar 

  15. Wu WY, Yang WZ, Hou JJ, Guo DA. Current status and future perspective in the globalization of traditional Chinese medicines. World J Tradit Chin Med 2015; 1(1): 1–4

    Article  Google Scholar 

  16. Qu L, Zou W, Zhou Z, Zhang T, Greef J, Wang M. Non-European traditional herbal medicines in Europe: a community herbal monograph perspective. J Ethnopharmacol 2014; 156: 107–114

    Article  PubMed  Google Scholar 

  17. Pan M, Ying SL. Research progress on international education promoting the internationalization of traditional Chinese medicine. J Chengdu Univ Tradit Chin Med (Chengdu Zhong Yi Yao Da Xue Xue Bao) 2015; 17(2): 6–7 (in Chinese)

    Google Scholar 

  18. Zhang YB, Lu XF. Foreign exchange and cooperation of Chinese medicine and influence since the reform and opening up. Med Soc (Yi Xue Yu She Hui) 2015; 28(4): 14–16 (in Chinese)

    Google Scholar 

  19. Li J. Current situation and thinking of the development of higher education of TCM in China. Northwest Med Educ (Xi Bei Yi Xue Jiao Yu) 2010; 18(5): 857–887 (in Chinese)

    Google Scholar 

  20. National Bureau of Statistics of the People’s Republic of China. Statistical Data, Nov. 16, 2015. http://www.stats.gov.cn/tjsj/

  21. China Chamber of Commerce for Import & Export of Medicines & Health Products. Statistical Data, Nov. 16, 2015. http://www.cccmhpie.org.cn/Pub/3317_List.shtml

  22. Uzuner H, Fan TP, Dias A, Guo DA, El-Nezami HS, Xu Q. Establishing an EU-China consortium on traditional Chinese medicine research. Chin Med 2010; 5(1): 42–47

    Article  PubMed  PubMed Central  Google Scholar 

  23. Fan DM. Holistic integrative medicine. Am J Dig Dis 2014; 1(1): 22–36

    Google Scholar 

  24. Fan DM. Medicine and science. Negative (Yi Xue Zheng Ming) 2015; 6(2): 1–19 (in Chinese)

    Google Scholar 

  25. Fung FY, Linn YC. Developing traditional Chinese medicine in the era of evidence-based medicine: current evidences and challenges. Evid Based Complement Alternat Med 2015;2015:425037

    Article  PubMed  PubMed Central  Google Scholar 

  26. Jiang M, Yang J, Zhang C, Liu B, Chan K, Cao H, Lu A. Clinical studies with traditional Chinese medicine in the past decade and future research and development. Planta Med 2010; 76(17): 2048–2064

    Article  CAS  PubMed  Google Scholar 

  27. Fan DM. Exploration of Medicine Development. Xi’an: The Fourth Military Medical University press, 2014 (in Chinese)

    Google Scholar 

  28. Ding Q, Liu FH, Liu Y, Cao C. Plant drug quality control strategy abroad and enlightenment to traditional Chinese medicine development in China. Chin Inform Tradit Chin Med (Zhongguo Zhong Yi Yao Xin Xi Za Zhi) 2011; 18(3): 1–4 (in Chinese)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Jing Cheng or Daiming Fan.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, Y., Yang, Z., Cheng, J. et al. Barriers and countermeasures in developing traditional Chinese medicine in Europe. Front. Med. 10, 360–376 (2016). https://doi.org/10.1007/s11684-016-0455-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11684-016-0455-x

Keywords

Navigation